Paper3758143
Evaluation of once daily endralazine in hypertension.
Wu R and 2 others. Eur J Clin Pharmacol, 1986. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of once daily endralazine in hypertension. Papers, record 3758143. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3758143
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Hypertension | Major topic |
| Pyridazines | Major topic |
| Acetylation | |
| Adult | |
| Aged | |
| Blood Pressure | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7298742 | Sensitive high-performance liquid chromatographic assay for endralazine and two of its metabolites in human plasma. | J Chromatogr | 1981 | https://conductscience.org/library/papers/7298742 | PubMed |
| 2 | 6882620 | The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6882620 | PubMed |
| 3 | 857459 | [Hemodynamic study on a new antihypertensive drug (a pyridopyridazine) in the treatment of hypertensive crisis and resistent hypertension. First findings in man (author's transl)]. | Z Kardiol | 1977 | https://conductscience.org/library/papers/857459 | PubMed |
| 4 | 3918712 | Hydralazine induced lupus syndrome with eye disease. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3918712 | PubMed |
| 5 | 26870 | [Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)]. | MMW Munch Med Wochenschr | 1978 | https://conductscience.org/library/papers/26870 | PubMed |
| 6 | 7050561 | Hydralazine and related compounds: chemistry, metabolism, and mode of action. | Med Res Rev | 1981 | https://conductscience.org/library/papers/7050561 | PubMed |
| 7 | 6132036 | Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect. | Lancet | 1983 | https://conductscience.org/library/papers/6132036 | PubMed |
| 8 | 7343274 | [Management of treatment-resistant hypertension: comparison of the antihypertensive effect of endralazine and minoxidil (author's transl)]. | Dtsch Med Wochenschr | 1981 | https://conductscience.org/library/papers/7343274 | PubMed |
| 9 | 6181329 | Endralazine, a new peripheral vasodilator--a randomized cross-over trial against dihydralazine. | J Cardiovasc Pharmacol | 1982 | https://conductscience.org/library/papers/6181329 | PubMed |
| 10 | 232662 | [Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)]. | Arzneimittelforschung | 1979 | https://conductscience.org/library/papers/232662 | PubMed |
| 11 | 546422 | [Bicyclic 3-hydrazinopyridazines with antihypertensive action (author's transl)]. | Arzneimittelforschung | 1979 | https://conductscience.org/library/papers/546422 | PubMed |
| 12 | 55060 | Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators. | Acta Med Scand | 1975 | https://conductscience.org/library/papers/55060 | PubMed |
| 13 | 7259927 | Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7259927 | PubMed |
| 14 | 7296843 | Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status. | Clin Chem | 1981 | https://conductscience.org/library/papers/7296843 | PubMed |
| 15 | 6984902 | Endralazine in patients with severe hypertension and renal insufficiency. | Postgrad Med J | 1982 | https://conductscience.org/library/papers/6984902 | PubMed |
| 16 | 92167 | Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide. | Acta Med Scand | 1979 | https://conductscience.org/library/papers/92167 | PubMed |
| 17 | 7471604 | Effect of dose on acetylator phenotype distribution of hydralazine. | Clin Pharmacol Ther | 1981 | https://conductscience.org/library/papers/7471604 | PubMed |
| 18 | 6749347 | Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension. | Clin Exp Hypertens A | 1982 | https://conductscience.org/library/papers/6749347 | PubMed |
| 19 | 6364562 | [Experience with endralazine in the treatment of essential hypertension]. | Vnitr Lek | 1984 | https://conductscience.org/library/papers/6364562 | PubMed |
| 20 | 6974555 | Relationship between immune response to hydralazine and to deoxyribonuclease in patients receiving hydralazine. | Arthritis Rheum | 1981 | https://conductscience.org/library/papers/6974555 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 3609114 | Effect of food intake on plasma levels and antihypertensive response during maintenance therapy with endralazine. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3609114 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3758143
GET https://conductscience.org/api/papers/v1/3758143/references?page=2